Traditional Chinese medicine targeting apoptotic mechanisms for esophageal cancer therapy

Acta Pharmacologica Sinica

Volumn 37, Issue 3, 2016, Pages 295-302

  Zhang, Yu Shuang ^a,b   Shen, Qiang ^c   Li, Jing ^a,b  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Dysphagia Key Laboratory of Chinese Medicine of Hebei Province   (China)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

apoptosis; esophageal cancer; traditional Chinese medicine (TCM)

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE; CHINESE DRUG; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; DEATH RECEPTOR; FAS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; PROTEINASE; SURVIVIN; HERBACEOUS AGENT;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CELL CYCLE ARREST; CHINESE MEDICINE; DOWN REGULATION; DRUG TARGETING; ENDOPLASMIC RETICULUM STRESS; ENZYME REGULATION; ESOPHAGEAL CANCER CELL LINE; ESOPHAGUS CANCER; HUMAN; INTRACELLULAR SIGNALING; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MOLECULARLY TARGETED THERAPY; NONHUMAN; PROTEIN EXPRESSION; REVIEW; ANIMAL; DRUG EFFECTS; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; METABOLISM; PATHOLOGY; PROCEDURES;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASES; DRUGS, CHINESE HERBAL; ENDOPLASMIC RETICULUM STRESS; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; HUMANS; MEDICINE, CHINESE TRADITIONAL; MITOCHONDRIA; MOLECULAR TARGETED THERAPY; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 84959576182     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2015.116     Document Type: Review

References (74)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008:GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-917.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
3. Kerr JFR. Apoptosis: a basic biological phenomenon with wind-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239.
4. Yang L, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, et al. Prevention of apoptosis by bcl-2: release of cytochrome c from mitochondria blocked. Science 1997; 275: 1129-32.
5. Cheng EH, Kirsch DG, Clen RJ, Ravi R, Kastan MB, Bedi A, et al. Conversion of bal-2 to a bax-like death effector by caspases. Science 1997; 278: 1966-8.
6. Dudits D, Abraham E, Miskolczi P, Ayaydin F, Bilgin M, Horvath GV. Cell-cycle control as a target for calcium, hormonal and developmental signals: the role of phosphorylation in the retinoblastoma-centred pathway. Ann Bot 2011; 107: 1193-202.
7. Zhang H, Li Q, Li Z, Mei Y, Guo Y. The protection of Bal-2 overexpression on rat cortical neuronal injury caused by analogous is chemia/reperfusion in vitro. Neurosci Res 2008; 62: 140-6.
8. Yang D, Yaguchi T, Nakano T, Nishizaki T. Adenosine activates AMPK to phosphorylate Bcl-X(L) responsible for mitochondrial damage and DIABLO release in HuH-7 cells. Cell Physiol Biochem 2011; 27: 71-8.
9. Yang XD, Zhang J, Wang W. The expression of survivin and Bax in human esophageal cancer EC-9706 cells and interference of Chinese Medicine. J Tradit Chin Med 2010; 9:61-2.
10. Yang XD, Zhang J, Wu YJ, Zhang CJ, Dong K. The gene expression of bcl-2 and Fas in human esophageal epithelia EC-9706 cells and interference of Chinese Medicine. J Mudanjiang Med College 2010; 31: 1-2.
11. Wang XL, Wang JG, Song JY, Li RF. Effect of gecko alcohol extract on expression of proliferation and apoptosis related protein in human esophageal cancer cells EC9706. LiShizhen Med Mater Med Res 2010; 21: 887-9.
12. Huang T, Li XH, Zou CP, Li XC, Feng DP. Killing effect of osteosarcoma cells induced by combination of AiDi and carboplatin. Mod Oncol 2012;20:469-72.
13. Lu HD, Feng Q, Lei Z, Kong QZ. Inhibition of proliferation and promotion of apoptosis by the combination of AiDi with cisplatin in human esophageal carcinoma Eca-109 cell lines. Chin Hosp Pharm J 2013; 33: 1217-21.
14. Li YL, Wang LX, Fan QX, Wang RL, Zhao PR, Xia J, et al. Effect of Acanthopanax senticosus saponin on Inhibition tumor of EC9706 nude mice model. Shangdong Med J 2008; 48: 49-50.
15. Du HX, Jiang J, Geng GQ, Yao CC, Chen JP, Zhang Y, et al. Effects of matrine on apoptosis and the expression of Bcl-2/Bax of esophageal cancinoma cell. Pract Clin J Integr Tradit Chin West Med 2009; 9: 6-7.
16. Pei YX, Heng ZC, Duan GC, Zhang ZZ, Wang MC, Hu CL, et al. Effects and mechanism of lutein on apoptosis of esophageal carcinoma EC9706 cells. Chin J Chin Mater Med 2007; 32: 332-4.
17. Tomita N. BCL2 and MYC dual-hit lymphoma/leukemia. J Clin Exp Hematop 2010;51:7-12.
18. Freitas S, Costa S, Azevedo C, Carvalho G, Freire S, Barbosa P, et al. Flavonoids inhibit angiogenic cytokine production by human glioma cells. Phytother Res 2011; 25: 916-21.
19. Lei QX, Zhao LM, Yan X, Zhang Q, Shan B, Geng YM, et al. Ethanol extract from forsythia suspensa leaf suppresses human esophageal carcinoma cells growth. Cancer Res Prev Treatment 2012; 39: 394-9.
20. Guo HL, Li JH, Li B, Du CH, Zhang L. Regulatory mechanisms of apoptosis of actinidia arguta on human carcinoma of esophagus eca-109 cells. Pract J Cancer 2011; 26: 120-3.
21. Jin Y, Hu JL, Peng G, Liu W. Effect of oxymatrine on the apoptosis of human esophageal carcinoma Eca109cell line. Chin Hosp Pharm J 2009; 29: 891-4.
22. Huang JH, You YJ, Zheng J. Molecular mechanism of casticin to induce apoptosis on esophagus carcinoma cells. Transl Med J 2013; 2: 197-9.
23. Jiao F, Huang HJ. Research on effects of pterostilbene on growth of human esophageal cancer cell EC9706 and its mechanism. Med J Nat Defend Forces Southwest China 2012; 22: 827-30.
24. Xu X, Peng LT. Effect of norcantharidin on apoptosis of human esophageal cancer cell Eca-109 and its possible mechanism. Tumor 2010; 30: 666-70.
25. Peng LT, Xu X. Ginsenoside Rh2 up-regulates caspase 3 and caspase 8 expression in human esophageal cancer cell line Eca-109. World Chin J Dig 2010; 18: 3838-42.
26. Liu L, Zuo LF, Wang J. Effects of artesunate on membrane potential of mitochondria and cell apoptosis of Ec9706 cells. Med J Chin PLA 2014; 39: 25-9.
27. Xin QF, Chen JH, Xie XY, Shen ZY. Morphological and functional changes of mitochondrial in apoptotic esophageal carcinoma cell induced by oridonin. Mod Oncol 2013; 21: 239-41.
28. Bai ML, Li YJ, Jin CT. Effects of deguelin on the induction of apoptosis of human esophageal cancer cells Ec-109. Chin J Gerontol 2013; 33: 2849-50.
29. Song JY, Wang XL, Wang JG, Xi SM, Liu L, Li RF, et al. Inhibitory effects of gecko alcohol extract on human esophageal squamous carcinoma cell line EC-109 proliferation and associated mechanism. Chin Med Mat 2011; 34: 1020-3.
30. Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 1986; 46: 705-16.
31. Dong Y, Luo HS. The effects of curcumenol combined cisplatin on proliferation, apoptosis and nuclear factor κB expression of human esophageal cancer 109 cell. J Chin Intern Med 2015; 32: 202-4.
32. Tian F, Chai YR, Jiang YN, Zhang XY. The effect of curcumin through suppression of IκBα phosphorylation on inhibition of proliferation of esophageal squamous cell carcinoma cell lines. Basic Clin Med 2011; 31: 767-72.
33. Luo L, Li DM. Apoptosis of human esophageal cancer cell EC9706 induced by parthenolide. China J Mod Med 2010; 20: 2658-61.
34. Logue SE, Cleary P, Saveljeva S, Samali A. New directions in ER stress-induced cell death. Apoptosis 2013; 18: 537-46.
35. Verfaillie T, Garg AD, Agostinis P. Targeting ER stress induced apoptosis and inflammation in cancer. Cancer Lett 2013; 332: 249-64.
36. Kaufman RJ. Orchestrating the unfolded protein response in health and disease. J Clin Invest 2002; 110: 1389-98.
37. Cao S, Han QQ, Fu Q, Zhu YQ. Effect of apoptosis on implanted human esophageal carcinoma in nude mouse by Oxymatrine Injection. China J Tradit Chin Med Pharm 2014; 29: 2047-9.
38. Takai N, Miyazaki T, Nishida M. Expression of survivin is associated with malignant potential in epithelial ovarian carcinoma. Int J Mol Med 2002; 10: 211-6.
39. Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T, Tanigawa N. Inhibition of apoptosis by surviving predicts shorter survival rates in colorectal cancer. Cancer Res 1998; 58: 5071-4.
40. Rodel F, Hoffmann J, Distel L, Herrmann M, Noisternig T, Papadopoulos T, et al. Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer. Cancer Res 2005; 65: 4881-7.
41. Kato J, Kuwabara Y, Mitani M, Shinoda N, Sato A, Toyama T, et al. Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy. Int J Cancer 2001; 95: 92-5.
42. Rosato A, Pivetta M, Parentia A, Laderosa GA, Zoso A, Milan G, et al. Survivin in esophageal cancer: an accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma. Int J Cancer 2006; 119: 1717-22.
43. Wu YW, Tong J, Zhang FW, Liao GP. Effect of Tetrandrine on apoptosis related gene Survivin and Caspase-3 of esophageal cancer cells. Chin Med Mat 2013; 36: 986-8.
44. Krysan K, Dalwadi H, Sharma S, Pold M, Dubinett S. Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer. Cancer Res 2004; 64: 6359-62.
45. Dalwadi H, Krysan K, Heuze-Vourc'h N, Dohadwala M, Elashoff D, Sharma S, et al. Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer. Clin Cancer Res 2005;11: 7674-82.
46. Zhang ZD, Jiang C, Yan YH. Effect of sinomenine on proliferation and apoptosis of ECl09 cell through COX-2 pathway. Res Integr Tradit Chin West Med 2012; 4: 241-3.
47. Liu SH, Sun GP, Yang Z, Wan XA, Wang ZG, Wu HY. Investigation of apoptosis mechanism of Pae on human esophageal cancer Eca-109 cell carcinoma xenograft in nude mice. Chin Pharmacol Bull 2008; 24: 457-60.
48. Wang LF, Shan BE, Liu LH, Ren FZ, Shan TQ. Effect of baohuoside 1 from Cortex Periplocae on proliferation and apoptosis of esophageal carcinoma cells. Tumor 2009; 29:123-6.
49. Wang LF, Liu LH, Ma YM, Meng MR, Shan TQ, Shan BE. Triterpenes compound extracted from cortex periplocae inhibits tumorigenesis of esophageal cancer Eca109 cells in nude mice and related mechanisms. Chin J Cancer Biother 2010; 17: 620-4.
50. Fuchs SY, Adler V, Buschmann T, Yin Z, Wu X, Jones SN, et al. JNK targets P53 ubiquitination and degradation in nonstressed cells. Genes Dev 1998; 12: 2658-63.
51. Zheng YL,Sun TZ. Effect of oral liquid dihuang guanshi tong on cell apoptosis and relevant controlling gene protein in esophageal carcinoma with radiotherapy. Chin J Clin Rehabil 2006; 10: 111-4.
52. Chen SS, Jia YS, Tian FL, Yan X, Cao HJ, Qing LJ, et al. Contrast research of the expression of p53 and survivin on tonglian decoction combined with microwave thermal therapy and simple microwave thermal therapy on esophageal cancer. J Jiangsu Tradit Chin Med 2014; 46: 34-5.
53. Massagu J. G1 cell-cycle control and cancer. Nature 2004; 432: 298-306.
54. Shamma A, Doki Y, Shiozaki H, Tsujinaka T, Jnoue M, Yano M, et al. Effect of cyclinD1 and associated proteins on proliferation of esophageal squamous cell carcinoma. Int J Oncol 1998; 13: 455-60.
55. Zhang J, Li Y, Wang R, Wen D, Sarbia M, Kuang G, et al. Association of cyclin D1 (G870A)polymorphism with susceptibility to esophageal and gastric cardiac carcinoma in a northern Chinese population. Int J Cancer 2003; 105: 281-4.
56. Nozoe T, Korenaga D, Kabashima A, Ohga T, Saeki H, Sugimachi K. Significance of cyclinB1 expression as an independent prognostic indicator of patients with squamous cell carcinoma of the esophagus. Clin Cancer Res 2002; 8: 817-22.
57. Takeno S, Noguchi T, Kikuchi R, Uchida Y, Yokoyama S, Muller W. Prognostic value of cy-clinB1 in patients with esophageal squamous cell carcinoma. Cancer 2002; 94: 2874-81.
58. Liu XX, Liu HZ, Chen JH, Chen YM, Shan BE. Effect of baohuoside-1 on proliferation and cell cycle of human esophageal carcinoma cell Eca-109. Chin Tradit Herbal Drugs 2009; 40: 1590-3.
59. Liu XX, Zhang YZ, Li ZH, Li JM, Chen JH, Shan BE. Effect of baohuoside-I on Wnt/β-catenin signaling pathway of human esophageal carcinoma cell Eca-109. Chin Tradit Herbal Drugs 2011; 42: 124-6.
60. Zhang ZW, Yan WQ, Li CX, Wang DB, Li ZG, Si CL, et al. Suppression effect on proliferation of esophageal cancer cell with extracts of walnut green seedcase. Chin J Surg Integr Tradit West Med 2014; 20: 43-6.
61. Hu H, Jing XB, Cai XB, Wang QJ. The study of the proliferation inhibition of curcumin on EC-109 cells. Pract J Cancer 2011; 26: 230-3.
62. Zhang Q, Zhao XH. Molecular mechanism of flavones and flavonols on the induction of cell cycle arrest in human esophageal carcinoma cells. Prog Biochem Biophys 2008; 35: 1031-8.
63. Lee SH, Park C, Jin CY, Kim GY, Moon SK, Hyun JW, Lee WH, et al. Involvement of extracellular signal-related kinase signaling in esculetin induced G1 arrest of human Leukemia U937 cells. Biomed Pharmcother 2008; 62: 723-9.
64. Chang HR, Lian JD, Lo CW, Huang HP, Wang CJ. Aristolochic acid-induced cell cycle G1 arrest in human urothelium SV-HUC-1 cells. Food Chem Toxicol 2007; 45: 396-402.
65. Shang XH, Shang XL, Shan BE, Chen YM, Ren FZ, Liu XX. Ethyl acetate extract from Cortex periplocae induced apoptosis of human esophageal carcinoma cell line TE-13. Tumor 2010; 30: 6-10.
66. Zhao LM, Shan BE, Ai J, Ren FZ, Lian YS, Song XT. Inhibitory effects of periplocin from Cortex Periplocae on proliferation of human esophageal carcinoma TE-13 cells. Tumor 2008; 28: 203-6.
67. Nozoe T, Oyama T, Takenoyanma M, Hanagirl T, Sugio K, Yasumoto K. Significance of immunohistochemical expression of p27 and involucrin as the marker of cellular differentiation of squamous cell carcinoma of the esophagus. Oncology 2006; 71: 402-10.
68. Chen GQ, Shen Y, Duan H, Tang WX, Chen YL. Effects and mechanisms of ursolic acid on inducing apoptosis of human esophageal carcinoma cell line Eca-109. Tradit Chin Drug Res Clin Pharmacol 2008; 19: 454-8.
69. Liu WM. The expression and clinical significance of P21 gene in esophageal cancer tissues. J Basic Clin Oncol 2007;20:173-4.
70. Liu HM. The expression of p21 and p16 gene in human early esophageal carcinoma. China Foreign Med Treatment 2010; 17: 28-9.
71. Li L, Qi FY, Liu JR, Zuo LF. Effects of ginsenoside Rh2 (GS-Rh2)on cell cycle of Eca-109 esophageal carcinoma cell line. Chin J Chin Mater Med 2005; 30: 1617-21.
72. Li J, Liu YX, Xing YX, Lu FH, Zhou JC. Effects of Qigefang on adhesion of human esophageal cancer cell line EC109 and human gastric cancer cell line MGC. Chin J Basic Med Tradit Chin Med 2007; 13: 459-60.
73. Li J, Li N, Liu YX, Lu FH, Fu XM. Effects of Qigefang on cell proliferation, movement, secreting MMP-2 and MMP-9 of MGC gastric cancer cell line. Chin J Inform Tradit Chin Med 2010; 17: 36-8.
74. Li J, Liu YX, Lu FH, Li N, Huo BJ. Research of Qigefang on inhibiting pulmonary metastasis of forestomach cancer in mice. J Sichuan Tradit Chin Med 2010; 28: 20-2.